EUVIMEDEUVIMED entdecken
Open Access

Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma

Reshma David, Rehmatullah Khan

Cureus · 14.11.2026

DOI: 10.7759/cureus.119661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 14.11.2026. Verfasst von Reshma David und 1 weiteren Autor:innen. Beteiligte Einrichtung: Acute Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapyhospitalizationmalignant pleural mesothelioma (mpm)overall survivalprogression-free survival (pfs)

Autor:innen und Institutionen

  • Acute Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
  • Oncology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.

Zitieren

APA

David, R., & Khan, R. (2026). Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma. Cureus. https://doi.org/10.7759/cureus.119661

Vancouver

David R, Khan R. Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma. Cureus. 2026. doi:10.7759/cureus.119661

BibTeX
@article{David2026,
  author = {David, Reshma and Khan, Rehmatullah},
  title = {Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119661}
}
Kostenlos starten →